Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia
IGF-1 Elevation: Full GH therapy consistently elevates IGF-1 levels, which concerns oncologists due to potential proliferative effects on existing cancers
It targets three key receptors, GLP-1, GIP, and GCG (glucagon)
Combined-pathway designs Explored in study designs comparing single peptides against a balanced dual blend
US$ 24.27
US$ 29.43
US$ 27.67
